The U.S. Food and Drug Administration (FDA) on Friday unveiled a proposed regulation aimed at strengthening oversight of tobacco products imported into the United States. The rule would mandate foreign tobacco manufacturers to register their production facilities and provide detailed information about the products they sell domestically, with the objective of curbing illegal imports, including youth-popular e-cigarettes.
Under the proposed regulation, both foreign and domestic entities involved in the manufacturing, preparation, or processing of tobacco products would be subjected to the registration and reporting requirements. The rule is expected to impact major international tobacco firms such as British American Tobacco, Japan Tobacco, and Imperial Brands, as well as smaller overseas producers of e-cigarettes whose goods enter the U.S. market.
The FDA’s proposal requires manufacturers to submit identifying information for each tobacco product, including specifics like nicotine concentration and source, flavor profiles, packaging types, and product dimensions. For e-cigarettes, additional data would be required, including e-liquid volume, battery capacity, and wattage. This level of detail is intended to enhance the agency’s ability to trace and control tobacco product flows, particularly to prevent unauthorized or counterfeit items from reaching consumers.
All registrations and product listings would be submitted electronically through the FDA’s designated online portal. Facilities would be obligated to update their registrations annually, while product listings would need to be refreshed twice a year to ensure the agency maintains current information.
The FDA said these measures are part of broader efforts to combat illegal tobacco imports that can evade regulatory safeguards, contributing to public health risks. The agency emphasized that detailed product tracking and facility registration will enable more effective enforcement actions against unauthorized products, especially in the rapidly evolving e-cigarette market.
The proposal is subject to a public comment period before any final rule is issued, allowing stakeholders, including manufacturers and public health groups, to provide input on the potential impact and scope of the regulation.
